Results 61 to 70 of about 9,102 (179)
Association between CYP2B6 polymorphism and acute leukemia in a Han population of Northwest China
Background The aim of this study was to investigate potential associations between CYP2B6 c.516G>T polymorphism and the occurrence and prognosis of acute leukemias (AL) in the Han population of Northwest China.
Li‐Li Yu, Wei Zhang, Juan Li, Li Zhao
doaj +1 more source
Pharmacogenomic‐guided managment of behavioral symptoms within the 4Ms framework.
Gianna Franco +3 more
wiley +1 more source
The effects of CYP2B6 inactivators on the metabolism of ciprofol
Ciprofol is a novel short-acting intravenous anaesthetic developed in China that is mainly metabolized by cytochrome P450 2B6 (CYP2B6) and uridine diphosphate glucuronosyltransferase 1A9 (UGT1A9). Currently, insufficient evidence is available to support drug‒drug interactions between ciprofol and CYP2B6 inactivators.
Ming Lu +6 more
openaire +3 more sources
The prescription of patients' tailored anti-infectious treatments is the ultimate goal of pharmacogenetics/genomics applied to antimicrobial treatments, providing a basis for personalized medicine. Despite the efforts to screen Africans for alleles underlying defective metabolism for a panel of different drugs, still more research is necessary to ...
RUSSO, Gianluca +8 more
openaire +3 more sources
Periodontal Infectogenomics in Africa: The Biological Case for a Population‐Centred Research Agenda
African populations harbour the greatest human genetic diversity on earth and carry the highest global burden of severe periodontitis, yet their absence from periodontal infectogenomics represents a biological limitation of the field with profound implications for host‐microbe interaction research.
Salma Kabbashi, Manogari Chetty
wiley +1 more source
Efavirenz Intoxication Due to a New Cyp2B6 Constellation
Here, we describe severe neuropsychiatric symptoms in an HIV-positive Asian man with extremely high efavirenz plasma levels while receiving standard treatment with efavirenz/tenofovir/emtricitabine fixed-dose regimen. Genetic examination revealed compound homozygosity for loss-of-function alleles of CYP2B6, including coding for a rare truncated protein.
Anagnostopoulos, Alexia +6 more
openaire +4 more sources
Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont +5 more
wiley +1 more source
To characterize the prevalence of CYP2B6 and OPRM1 gene polymorphisms and evaluate their associations with serum methadone concentrations and dose requirements in Vietnamese patients undergoing methadone maintenance treatment (MMT).
Nguyen Quynh Giao +4 more
doaj +1 more source
Efavirenz is metabolized by CYP2B6, an inducible enzyme whose expression is regulated by the constitutive androstane receptor and pregnane X receptor nuclear receptors. CAR and PXR are encoded by genetically polymorphic NR1I2 and NR1I3, respectively.
Zelalem Petros +3 more
doaj +1 more source
ABSTRACT Metabolic dysfunction–associated steatotic liver disease (MASLD) is the most common chronic liver disorder worldwide, affecting approximately one‐third of the population and increasing the risk of severe hepatic and cardiovascular complications.
Shurui Yang +4 more
wiley +1 more source

